z-logo
HomeZAIABlog
open-access-imgOpen Access
In Reply
Author(s) -
Corty Robert W.
Publication year - 2021
Publication title -
the oncologist
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13982
Subject(s) - medicine , gemcitabine , adverse effect , intensive care medicine , cancer
This letter to the editor responds to remarks on the authors’ article reporting on gemcitabine‐related adverse events associated with antibacterial use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.